Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women

Korean Journal of Internal Medicine

Volumn 20, Issue 1, 2005, Pages 33-39

  Ko, Hong Sook ^a   Kim, Chee Jeong ^a,b   Ryu, Wang Seong ^a  

^a Chung Ang University   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

Hormones; Lipids; Lipoproteins; Overweight; Women

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART PROTECTION; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBESITY; RISK FACTOR;

EID: 19444362869     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2005.20.1.33     Document Type: Article

References (39)

1. Guetta V, Cannon RO 3rd. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 93: 1928-1937, 1996
2. Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 92:5-8, 1995
3. Knopp RH. The effect of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet Gynecol 72: 23S-30S, 1988
4. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037, 1992
5. Williams JK, Adams MR, Klophenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-1687, 1990
6. Negre-Salvayre A, Pieraggi MT, Mabile L, Salvayre R. Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 99:207-217, 1993
7. Kim CJ, Jang HC, Cho DH, Min YK. Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Arterioscer Thromb 14:275-281, 1994
8. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273:199-208, 1995
9. Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH. Effect of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women: influence of various progesterones and the duration of therapy. Arch Intern Med 156:1693-1700, 1996
10. Adams MR, Register TC, Golden DL, Wagner JD, Williams JK. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 17:217-221, 1997
11. Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty FK, Wilson PW, Levy D, Muller JE, Tofler GH. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 91:1952-1958, 1995
12. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133:933-941, 2000
13. Psaty BM, Heckbert SR, Atkins D, Lemaitre R, Koepsell TD, Wahl PW, Siscovick DS, Wagner EH. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 154:1333-1339, 1994
14. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-613, 1998
15. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith SC Jr, Taubert KA, Wenger NK. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 104:499-503, 2001
16. Petitti DB. Hormone replacement therapy and heart disease prevention: experimentation trumps observation. JAMA 280:650-652, 1998
17. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Oskene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288:321-333, 2002
18. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097-1105, 1999
19. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968-977, 1983
20. Hansen BC. The metabolic syndrome X. Ann N Y Acad Sci 892:1-24, 1999
21. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholestrol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
22. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 93:10022-10027, 1996
23. Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med 150:2557-2562, 1990
24. Newton KM, LaCroix AZ, McKnight B, Knopp RH, Siscovick DS, Heckbert SR, Weiss NS. Estrogen replacement therapy and prognosis after first myocardial infarction. Am J Epidemiol 145:269-277, 1997
25. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women. Circulation 75:1102-1109, 1987
26. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343:522-529, 2000
27. Angerer P, Stork S, Kothny W, Schmitt P, von Schacky C. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial. Arterioscler Thromb Vasc Biol 21:262-268, 2001
28. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 115:455-456, 1991
29. Petitti DB. Coronary heart disease and estrogen replacement therapy: can compliance bias explain the results of observational studies? Ann Epidemiol 4:115-118, 1994
30. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120-1131, 1989
31. Simpson ER, Merrill JC, Hollub AJ, Graham-Lorence S, Mendelson CR. Regulation of estrogen biosynthesis by human adipose cells. Endocr Rev 10:136-148, 1989
32. Semmens J, Rouse I, Beilin LJ, Masarei JR. Relationship of plasma HDL-cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and women. Metabolism 32:428-432, 1983
33. Longcope C, Herbert PN, McKinlay SM, Goldfield SR. The relationship of total and free estrogens and sex hormone-binding globulin with lipoproteins in women. J Clin Endocrinol Metab 71: 67-72, 1990
34. Soler JT, Folsom AR, Kaye SA, Prineas RJ. Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in post-menopausal women. Atherosclerosis 79:21-27, 1989
35. Cauley JA, Gutai JP, Kuller LH, Powell JG. The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women. Am J Epidemiol 132:884-894, 1990
36. Brownell KD, Stunkard AJ. Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction. Arch Intern Med 141:1142-1146, 1981
37. Pearce KF, Reboussin DM, Mayer-Davis E, Ephross S, Burke GL. Postmenopausal hormone replacement and obesity. Prim Care Update Ob Gyns 5:165, 1998
38. Bush TL, Fried LP, Barrett-Conner E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 34:B60-B70, 1988
39. Utermann G. The mysteries of lipoprotein(a). Science 246:904-910, 1989